Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2012, Article ID 402109, 7 pages
http://dx.doi.org/10.1155/2012/402109
Research Article

Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis

1PHARMO Institute for Drug Outcomes Research, P.O. Box 85222, 3508 AE Utrecht, The Netherlands
2Oncology Biometrics and Epidemiology, Oncology R&D, GlaxoSmithKline, RTP, NC 27709, USA
3The Nationwide Network and Registry for Histo- and Cytopathology in The Netherlands, Foundation PALGA, Utrecht, The Netherlands
4The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), 1066 CX Amsterdam, The Netherlands
5Department of Medical Informatics, Erasmus University Medical Centre, 3015 GE Rotterdam, The Netherlands

Received 5 March 2012; Accepted 26 March 2012

Academic Editor: Clement Trovik

Copyright © 2012 Myrthe P. P. van Herk-Sukel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. C. Borden, L. H. Baker, R. S. Bell et al., “Soft tissue sarcomas of adults: state of the translational science,” Clinical Cancer Research, vol. 9, no. 6, pp. 1941–1956, 2003. View at Google Scholar · View at Scopus
  2. F. Berrino, R. De Angelis, M. Sant et al., “Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study,” Lancet Oncology, vol. 8, no. 9, pp. 773–783, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Guideline soft tissue sarcoma, In Amsterdam: Nederlandse Werkgroep Weke Delen Tumoren (NWWDT), 2010.
  5. A. N. Van Geel, J. A. M. Van Unnik, R. B. Keus, and I. P. M. Van Beuningen, “Diagnosis and treatment of soft tissue tumours: the Dutch nationwide- accepted consensus,” Sarcoma, vol. 2, no. 3-4, pp. 183–191, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Van Geel, J. A. Van Unnik, and R. B. Keus, “Consensus soft tissue tumors. Dutch workgroup soft-tissue tumors,” Nederlands Tijdschrift voor Geneeskunde, vol. 139, no. 16, pp. 833–837, 1995. View at Google Scholar
  7. F. Ducimetière, A. Lurkin, D. Ranchère-Vince et al., “Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing,” PLoS ONE, vol. 6, no. 8, Article ID e20294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Skubitz and D. R. D'Adamo, “Sarcoma,” Mayo Clinic Proceedings, vol. 82, no. 11, pp. 1409–1432, 2007. View at Google Scholar
  9. G. Ottaviani and N. Jaffe, “The etiology of osteosarcoma,” Cancer Treatment and Research, vol. 152, pp. 15–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Gutierrez, E. A. Perez, D. Franceschi, F. L. Moffat Jr, A. S. Livingstone, and L. G. Koniaris, “Outcomes for Soft-Tissue Sarcoma in 8249 Cases from a Large State Cancer Registry,” Journal of Surgical Research, vol. 141, no. 1, pp. 105–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Levi, C. La Vecchia, L. Randimbison, and V. C. Te, “Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland,” European Journal of Cancer, vol. 35, no. 12, pp. 1711–1716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. H. H. Storm, “Survival of adult patients with cancer of soft tissues or bone in Europe. EUROCARE working group,” European Journal of Cancer, vol. 34, no. 14, pp. 2212–2217, 1998. View at Google Scholar
  13. A. Ferrari, I. Sultan, T. T. Huang et al., “Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database,” Pediatric Blood & Cancer, vol. 57, no. 6, pp. 943–949, 2011. View at Google Scholar
  14. J. W. W. Coebergh, M. L. G. Janssen-Heijnen, P. N. Post, and P. P. A. Razenberg, “Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996,” Journal of Clinical Epidemiology, vol. 52, no. 12, pp. 1131–1136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. G. Janssen-Heijnen, H. A. A. M. Maas, S. Houterman, V. E. P. P. Lemmens, H. J. T. Rutten, and J. W. W. Coebergh, “Comorbidity in older surgical cancer patients: influence on patient care and outcome,” European Journal of Cancer, vol. 43, no. 15, pp. 2179–2193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. O. Campos, B. J. Hassan, R. Riechelmann, and A. del Giglio, “Cancer-related fatigue: a review,” Revista da Associacao Medica Brasileira, vol. 57, no. 2, pp. 206–214, 2011. View at Google Scholar · View at Scopus
  17. E. R. Koomen, A. Joosse, R. M. C. Herings et al., “Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?” European Journal of Cancer, vol. 43, no. 17, pp. 2580–2589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. V. O. Dezentjé, N. J. C. Van Blijderveen, H. Gelderblom et al., “Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer,” Journal of Clinical Oncology, vol. 28, no. 14, pp. 2423–2429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. R. Koomen, A. Joosse, R. M. C. Herings, M. K. Casparie, H. J. Guchelaar, and T. Nijsten, “Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy,” Melanoma Research, vol. 19, no. 5, pp. 327–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. www.dutchhospitaldata.nl/, 2010.
  21. E. A. Mesri, E. Cesarman, and C. Boshoff, “Kaposi's sarcoma and its associated herpesvirus,” Nature Reviews Cancer, vol. 10, no. 10, pp. 707–719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. The International Agency for Research on Cancer, C. D. M. Fletcher, K. Krishnan Unni, and F. Mertens, Eds., WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone, IARC, Lyon, France, 2002.
  23. C. D. M. Fletcher, J. J. Berman, C. Corless et al., “Diagnosis of gastrointestinal stromal tumors: a consensus approach,” International Journal of Surgical Pathology, vol. 10, no. 2, pp. 81–89, 2002. View at Google Scholar · View at Scopus
  24. P. H. A. Nijhuis, M. Schaapveld, R. Otter, W. M. Molenaar, W. T. A. Van Der Graaf, and H. J. Hoekstra, “Epidemiological aspects of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials,” European Journal of Cancer, vol. 35, no. 12, pp. 1705–1710, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. Toro, L. B. Travis, J. W. Hongyu, K. Zhu, C. D. M. Fletcher, and S. S. Devesa, “Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology and End Results program, 1978–2001: an analysis of 26,758 cases,” International Journal of Cancer, vol. 119, no. 12, pp. 2922–2930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Wibmer, A. Leithner, N. Zielonke, M. Sperl, and R. Windhager, “Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review,” Annals of Oncology, vol. 21, no. 5, pp. 1106–1111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. E. Breslow and N. E. Day, “Statistical methods in cancer research. Volume II—the design and analysis of cohort studies,” IARC Scientific Publications, no. 82, pp. 1–406, 1987. View at Google Scholar · View at Scopus
  28. M. A. Clark, C. Fisher, I. Judson, and J. Meirion Thomas, “Soft-tissue sarcomas in adults,” New England Journal of Medicine, vol. 353, no. 7, pp. 701–711, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. E. Groopman and L. M. Itri, “Chemotherapy-induced anemia in adults: incidence and treatment,” Journal of the National Cancer Institute, vol. 91, no. 19, pp. 1616–1634, 1999. View at Google Scholar · View at Scopus
  30. F. Tas, Y. Eralp, M. Basaran et al., “Anemia in oncology practice: relation to diseases and their therapies,” American Journal of Clinical Oncology, vol. 25, no. 4, pp. 371–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. L. B. Harrison, D. Shasha, C. White, and B. Ramdeen, “Radiotherapy-associated anemia: the scope of the problem,” Oncologist, vol. 5, supplement 2, pp. 1–7, 2000. View at Google Scholar · View at Scopus
  32. M. P. P. van Herk-Sukel, L. V. van de Poll-Franse, V. E. P. P. Lemmens et al., “New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System,” European Journal of Cancer, vol. 46, no. 2, pp. 395–404, 2010. View at Publisher · View at Google Scholar · View at Scopus